These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27540260)

  • 61. Teaching developmentally disabled children with chronic illness to swallow prescribed capsules.
    Babbitt RL; Parrish JM; Brierley PE; Kohr MA
    J Dev Behav Pediatr; 1991 Aug; 12(4):229-35. PubMed ID: 1939677
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Power of personal goal sharing--treatment plan using personal goal maps for patients with mental disorders].
    Zhao Y
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1028-35. PubMed ID: 22187890
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oesophageal transit of six commonly used tablets and capsules.
    Hey H; Jørgensen F; Sørensen K; Hasselbalch H; Wamberg T
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1717-9. PubMed ID: 6816343
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low volume bowel preparation for colonoscopy: randomized, endoscopist-blinded trial of liquid sodium phosphate versus tablet sodium phosphate.
    Balaban DH; Leavell BS; Oblinger MJ; Thompson WO; Bolton ND; Pambianco DJ
    Am J Gastroenterol; 2003 Apr; 98(4):827-32. PubMed ID: 12738463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of Rectodispersible Tablets and Granulate Capsules for the Treatment of Serious Neonatal Sepsis in Developing Countries.
    Kauss T; Langlois MH; Guyonnet-Dupérat A; Phoeung T; Xie XY; Cartwright A; White N; Gomes M; Gaudin K
    J Pharm Sci; 2019 Aug; 108(8):2805-2813. PubMed ID: 30878515
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.
    Spomer N; Klingmann V; Stoltenberg I; Lerch C; Meissner T; Breitkreutz J
    Arch Dis Child; 2012 Mar; 97(3):283-6. PubMed ID: 22253279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
    Rubino M; Summers KH; Puenpatom A; Fu C; Ohsfeldt RL; Ben-Joseph RH
    J Manag Care Pharm; 2011 Jun; 17(5):367-76. PubMed ID: 21657806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Experimental Study on Patient Preferences Regarding the Shape and Size of Medical Tablets and Capsules Using Three-Dimensionally Printed Plastic Model Formulations.
    Kabeya K; Satoh H; Hori S; Sawada Y
    Patient Prefer Adherence; 2021; 15():863-870. PubMed ID: 33953546
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms.
    Binson G; Sanchez C; Waton K; Chanat A; Di Maio M; Beuzit K; Dupuis A
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371705
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
    Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
    J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radioiodine dispensing and usage in a centralized hospital nuclear pharmacy.
    Hung JC
    Thyroid; 1997 Apr; 7(2):289-94. PubMed ID: 9133703
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Manipulation of Hydrocortisone Tablets Leads to Iatrogenic Cushing Syndrome in a 6-Year-Old Girl With CAH.
    Al-Rayess H; Fleissner K; Jaber M; Brundage RC; Sarafoglou K
    J Endocr Soc; 2020 Aug; 4(8):bvaa091. PubMed ID: 32803093
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Barriers and enablers to switching from a solid to a liquid formulation of Parkinson's medication: a theory-based mixed methods investigation.
    Atkins B; Bhattacharya D; Smith C; Scott S
    Int J Clin Pharm; 2022 Aug; 44(4):1046-1056. PubMed ID: 35842516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 10 common questions on emergency contraception.
    Hatcher RA
    Contracept Technol Update; 1998 Jan; 19(1):6, 11-2. PubMed ID: 12348214
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
    Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Softgels: consumer perceptions and market impact relative to other oral dosage forms.
    Jones WJ; Francis JJ
    Adv Ther; 2000; 17(5):213-21. PubMed ID: 11186141
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).
    Alessandrini E; Brako F; Scarpa M; Lupo M; Bonifazi D; Pignataro V; Cavallo M; Cullufe O; Enache C; Nafria B; Claverol J; De Taeye L; Vermeulen E; Preston J; Tuleu C
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063499
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The KidzMed project: teaching children to swallow tablet medication.
    Tse Y; Vasey N; Dua D; Oliver S; Emmet V; Pickering A; Lim E
    Arch Dis Child; 2020 Nov; 105(11):1105-1107. PubMed ID: 31594776
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations.
    Bhosle M; Benner JS; Dekoven M; Shelton J
    Patient Prefer Adherence; 2009 Nov; 3():161-71. PubMed ID: 19936158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.